Leiomyosarcoma

3 trials 3 recruiting MedDRA PT
3 Registered trials
3 Recruiting
3 Unique sponsors
3 Unique IMPs
0 Commercial trials
Drug classes (ATC)
L Oncology (ATC L) 1
— ATC code not specified 2
Mechanism of action (INN-stem analysis)
Unknown / small molecule 2 substances
Antimetabolite 1 substance
Phase III: 2 Phase II: 1

Filter these 3 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 3 trials

Phase III

2 trials
  • European Organisation For Research And Treatment Of Cancer Academic
    IMP not specified
    2023-505261-84-00 10 countries 2020 n=180
    Recruiting
  • Universitaet Muenster Academic
    TTF-NGR
    2024-516392-33-00 1 country 2021 n=126
    Recruiting

Phase II

1 trial
  • Italian Sarcoma Group Academic
    GEMCITABINE; TRABECTEDIN
    2024-513820-40-00 1 country 2021 n=100
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Italian Sarcoma Group Academic 1 Phase II 1
European Organisation For Research And Treatment Of Cancer Academic 1 Phase III 1
Universitaet Muenster Academic 1 Phase III 1
New trials by year
2020
1
2021
2
← All indication landscapes